{gallery}News_25.04.2018{/gallery}

April 23-25 ​​in Moscow on the basis of National Medical Research Center of Pediatric Hematology, Oncology and Immunology (NMRC of PHOI) named after Dmitry Rogachev hosted a meeting of experts in the field of child cancer in CIS countries under the auspices of the WHO (World Health Organization) Regional Office for Europe (Eurasian region), the organizers of the meeting were WHO Children's Research Hospital of St. Jude (USA). In all, 11 countries took part in the meeting. The main goal of the meeting is to improve the survival of children with cancer in the Eurasian region and create a joint working group that unites the specialists of the region.

American, British and French specialists have presented interesting reports in the field of epidemiology of childhood cancer, the causes and risk factors for the development of childhood cancer. Today, more than 200,000 new cases of childhood cancer are diagnosed in the year, 80,000 children die from this disease, it is not possible to prevent cancer prevention in children because they are not exposed to risk factors as adults, and the intrauterine effect is more likely to cause oncological processes.

According to the International Organization for Research on Cancer, the causes of development of malignant neoplasm in a child in 20% are possible genetic disorders, it may also be important for the infected mother during pregnancy, exposure of parents to pesticides. But an interesting new fact! At children of being born with mass of the body more than 4000 grams, are increased the risk of development of oncological disease, and increase of weight at birth by 1 kg increases the risk of occurrence of cancer by 26%

One of the organizers of the meeting is the American hospital of St. Jude. The head of the hospital presented a report on the prospects of increasing the survival rate of children with leukemia up to 96%. They work under the slogan "no child should die at the dawn of life."

Today, in the world of 80,000 children newly infected with cancer, 80% live in countries with disabilities and do not have access to modern treatment. Therefore, on May 31, 2017, a meeting on pediatric oncology was held in the history of WHO, where it was decided to assist in strengthening health care to countries with disabilities. The main mission is assigned to the American hospital of St. Jude and the success in the Eurasian region in the treatment of children with cancer can be achieved with the help of state support, joint WHO work and cooperation with international experts from the world's leading centers. From Kazakhstan, in addition to SCPPS director R. Borabaeva, the head of oncological hematology, Dair Zhubanyshevich Nurgaliev participated. At the meeting, 4 countries were awarded with letters of gratitude from the National Medical Research Center of Pediatric Hematology, Oncology and Immunology (NMRC of PHOI) named after Dmitry Rogachev for active long-term work, among which is our center.

Riza Boranbaeva made a presentation on the development of the children's oncology and hematology service in Kazakhstan and said: "We were very pleased to receive positive feedback from the Heads of the centers from Russia and Belarus on the rapid development of our service. Of the Central Asian countries, only in Kazakhstan is the country fully provided with the treatment of children with cancer and transplantology is developing. We hope that such meetings will give a new impetus to the development of our service, will enable us to find the right ways in solving problems, and they are everywhere not only in our country. So the British specialists reported on the study, where in 3 out of 10 cases an incorrect morphological diagnosis was established and this is not always a problem of personnel qualification, in children the tumors are personified diseases and are associated with a violation of cellular regulation. That's such a complex and interesting profession in our country and to improve and achieve the tasks set can only be joint efforts ".